Logo image of INE.CA

INNERGEX RENEWABLE ENERGY (INE.CA) Stock Fundamental Analysis

TSX:INE - Toronto Stock Exchange - CA45790B1040 - Common Stock - Currency: CAD

8.95  +0.43 (+5.05%)

Fundamental Rating

2

INE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 40 industry peers in the Independent Power and Renewable Electricity Producers industry. INE may be in some trouble as it scores bad on both profitability and health. INE does not seem to be growing, but still is valued expensively. INE also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year INE has reported negative net income.
In the past year INE had a positive cash flow from operations.
In the past 5 years INE always reported negative net income.
In the past 5 years INE always reported a positive cash flow from operatings.
INE.CA Yearly Net Income VS EBIT VS OCF VS FCFINE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M -600M

1.2 Ratios

INE has a Return On Assets of -1.45%. This is in the lower half of the industry: INE underperforms 61.54% of its industry peers.
The Return On Equity of INE (-12.85%) is worse than 61.54% of its industry peers.
INE has a Return On Invested Capital of 2.68%. This is comparable to the rest of the industry: INE outperforms 53.85% of its industry peers.
The Average Return On Invested Capital over the past 3 years for INE is in line with the industry average of 4.67%.
Industry RankSector Rank
ROA -1.45%
ROE -12.85%
ROIC 2.68%
ROA(3y)-1.62%
ROA(5y)-1.18%
ROE(3y)-11.42%
ROE(5y)-8.74%
ROIC(3y)2.93%
ROIC(5y)2.75%
INE.CA Yearly ROA, ROE, ROICINE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

1.3 Margins

The Operating Margin of INE (29.65%) is better than 61.54% of its industry peers.
INE's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 76.64%, INE is doing good in the industry, outperforming 76.92% of the companies in the same industry.
INE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.65%
PM (TTM) N/A
GM 76.64%
OM growth 3Y2.21%
OM growth 5Y-4.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.39%
GM growth 5Y-1.18%
INE.CA Yearly Profit, Operating, Gross MarginsINE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INE is destroying value.
Compared to 1 year ago, INE has about the same amount of shares outstanding.
INE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, INE has a worse debt to assets ratio.
INE.CA Yearly Shares OutstandingINE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
INE.CA Yearly Total Debt VS Total AssetsINE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

INE has an Altman-Z score of 0.03. This is a bad value and indicates that INE is not financially healthy and even has some risk of bankruptcy.
INE has a Altman-Z score (0.03) which is comparable to the rest of the industry.
INE has a Debt/Equity ratio of 5.54. This is a high value indicating a heavy dependency on external financing.
INE has a Debt to Equity ratio of 5.54. This is comparable to the rest of the industry: INE outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.54
Debt/FCF N/A
Altman-Z 0.03
ROIC/WACC0.61
WACC4.37%
INE.CA Yearly LT Debt VS Equity VS FCFINE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B

2.3 Liquidity

INE has a Current Ratio of 0.56. This is a bad value and indicates that INE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.56, INE is doing worse than 69.23% of the companies in the same industry.
INE has a Quick Ratio of 0.56. This is a bad value and indicates that INE is not financially healthy enough and could expect problems in meeting its short term obligations.
INE has a Quick ratio of 0.56. This is in the lower half of the industry: INE underperforms 65.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
INE.CA Yearly Current Assets VS Current LiabilitesINE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

INE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.38%, which is quite good.
INE shows a small growth in Revenue. In the last year, the Revenue has grown by 3.96%.
Measured over the past years, INE shows a quite strong growth in Revenue. The Revenue has been growing by 16.69% on average per year.
EPS 1Y (TTM)15.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)3.96%
Revenue growth 3Y19.32%
Revenue growth 5Y16.69%
Sales Q2Q%-11.49%

3.2 Future

INE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 119.48% yearly.
Based on estimates for the next years, INE will show a decrease in Revenue. The Revenue will decrease by -0.58% on average per year.
EPS Next Y-758.5%
EPS Next 2Y41.42%
EPS Next 3Y-71.57%
EPS Next 5Y119.48%
Revenue Next Year2.41%
Revenue Next 2Y7.79%
Revenue Next 3Y4.04%
Revenue Next 5Y-0.58%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
INE.CA Yearly Revenue VS EstimatesINE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
INE.CA Yearly EPS VS EstimatesINE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

INE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INE.CA Price Earnings VS Forward Price EarningsINE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, INE is valued a bit more expensive than the industry average as 65.38% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.85
INE.CA Per share dataINE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

INE's earnings are expected to decrease with -71.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y-71.57%

7

5. Dividend

5.1 Amount

INE has a Yearly Dividend Yield of 4.23%, which is a nice return.
Compared to an average industry Dividend Yield of 4.45, INE has a dividend in line with its industry peers.
INE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 4.23%

5.2 History

The dividend of INE has a limited annual growth rate of 1.73%.
INE has been paying a dividend for at least 10 years, so it has a reliable track record.
INE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)1.73%
Div Incr Years0
Div Non Decr Years13
INE.CA Yearly Dividends per shareINE.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

INE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
INE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-86.39%
EPS Next 2Y41.42%
EPS Next 3Y-71.57%
INE.CA Yearly Income VS Free CF VS DividendINE.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M -600M

INNERGEX RENEWABLE ENERGY

TSX:INE (2/21/2025, 7:00:00 PM)

8.95

+0.43 (+5.05%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners36.62%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner ChangeN/A
Market Cap1.82B
Analysts73.85
Price Target11.58 (29.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.23%
Yearly Dividend0.74
Dividend Growth(5Y)1.73%
DP-86.39%
Div Incr Years0
Div Non Decr Years13
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-198.32%
Min EPS beat(2)-494.65%
Max EPS beat(2)98.02%
EPS beat(4)1
Avg EPS beat(4)-110.19%
Min EPS beat(4)-494.65%
Max EPS beat(4)98.02%
EPS beat(8)1
Avg EPS beat(8)-107.03%
EPS beat(12)2
Avg EPS beat(12)-104.89%
EPS beat(16)4
Avg EPS beat(16)-62.07%
Revenue beat(2)0
Avg Revenue beat(2)-4.99%
Min Revenue beat(2)-6.27%
Max Revenue beat(2)-3.71%
Revenue beat(4)0
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-6.27%
Max Revenue beat(4)-0.02%
Revenue beat(8)2
Avg Revenue beat(8)-1.28%
Revenue beat(12)5
Avg Revenue beat(12)-0.46%
Revenue beat(16)6
Avg Revenue beat(16)-0.38%
PT rev (1m)-3.81%
PT rev (3m)-3.81%
EPS NQ rev (1m)6.68%
EPS NQ rev (3m)6.68%
EPS NY rev (1m)17.07%
EPS NY rev (3m)5.56%
Revenue NQ rev (1m)-1.05%
Revenue NQ rev (3m)-1.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.78
P/FCF N/A
P/OCF 6.91
P/B 1.76
P/tB N/A
EV/EBITDA 11.85
EPS(TTM)-0.11
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-2.06
FCFYN/A
OCF(TTM)1.29
OCFY14.46%
SpS5.03
BVpS5.09
TBVpS-1.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.45%
ROE -12.85%
ROCE 3.72%
ROIC 2.68%
ROICexc 2.74%
ROICexgc 3.3%
OM 29.65%
PM (TTM) N/A
GM 76.64%
FCFM N/A
ROA(3y)-1.62%
ROA(5y)-1.18%
ROE(3y)-11.42%
ROE(5y)-8.74%
ROIC(3y)2.93%
ROIC(5y)2.75%
ROICexc(3y)2.99%
ROICexc(5y)2.82%
ROICexgc(3y)3.63%
ROICexgc(5y)3.38%
ROCE(3y)4.06%
ROCE(5y)3.82%
ROICexcg growth 3Y9.97%
ROICexcg growth 5Y4.22%
ROICexc growth 3Y9.56%
ROICexc growth 5Y4.28%
OM growth 3Y2.21%
OM growth 5Y-4.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.39%
GM growth 5Y-1.18%
F-Score6
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 5.54
Debt/FCF N/A
Debt/EBITDA 8.44
Cap/Depr 181.43%
Cap/Sales 66.69%
Interest Coverage 1.1
Cash Conversion 38.72%
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z 0.03
F-Score6
WACC4.37%
ROIC/WACC0.61
Cap/Depr(3y)107.71%
Cap/Depr(5y)197.83%
Cap/Sales(3y)37.35%
Cap/Sales(5y)70.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y-758.5%
EPS Next 2Y41.42%
EPS Next 3Y-71.57%
EPS Next 5Y119.48%
Revenue 1Y (TTM)3.96%
Revenue growth 3Y19.32%
Revenue growth 5Y16.69%
Sales Q2Q%-11.49%
Revenue Next Year2.41%
Revenue Next 2Y7.79%
Revenue Next 3Y4.04%
Revenue Next 5Y-0.58%
EBIT growth 1Y3.92%
EBIT growth 3Y21.95%
EBIT growth 5Y11.81%
EBIT Next Year136.69%
EBIT Next 3Y40.23%
EBIT Next 5Y27.75%
FCF growth 1Y-244.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.24%
OCF growth 3Y8.21%
OCF growth 5Y7.3%